Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia.
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
BMJ Open. 2019 Mar 23;9(3):e024266. doi: 10.1136/bmjopen-2018-024266.
To investigate mobile health product use in Australia and societal and clinician perceptions towards smartphone based visual acuity (VA) assessment tools.
Quantitative analysis of a cross-sectional survey delivered to the general public and thematic analysis of in-depth interviews of eye health clinicians.
Online survey within Australia and face-to-face in-depth interviews of clinicians.
1016 adults were recruited via Survey Monkey Audience, social media (Facebook and Twitter), Rotary Australia and Lions Clubs Australia. Six clinicians were recruited from private and public settings in Melbourne, Australia.
The study assessed socio-demographic characteristics, history of mobile health product use and perceived advantages and potential drawbacks of smartphone based VA assessment tools.
A total of 14.4% of the study population had previously used a mobile-based health product. After adjusting for covariates, younger age (p=0.001), male gender (p=0.01) and higher income (>$45 000) were associated with increased likelihood of having used a mobile health product (p=0.005). Seventy-two per cent of participants would use an automated smartphone based VA assessment tool, provided that the accuracy was on par to that of human assessors. Convenience (37.3%) and cost-savings (15.5%) were ranked as the greatest perceived advantages. While test accuracy (50.6%), a lack of personal contact with healthcare providers (18.3%) and data security (11.9%) were the greatest concerns. Themes to emerge from clinician qualitative data included the potential benefits for identifying refractive error in patients, as well as the ability to self-monitor vision. Concerns were raised over the potential misuse of self-testing vision apps and the inability to detect pathology.
Our findings suggest that a substantial proportion of the Australian population do not use mobile health products. Furthermore, there remains notable concerns, including test accuracy and data privacy, with smartphone-based VA assessment tools by both clinicians and the public.
调查澳大利亚移动医疗产品的使用情况以及社会大众和临床医生对基于智能手机的视力(VA)评估工具的看法。
对向公众提供的横断面调查进行定量分析,并对澳大利亚墨尔本的眼科临床医生进行深入访谈的主题分析。
在澳大利亚进行在线调查,并对临床医生进行面对面的深入访谈。
通过 Survey Monkey 受众、社交媒体(脸书和推特)、 Rotary澳大利亚和狮子俱乐部澳大利亚招募了 1016 名成年人。从澳大利亚私人和公共环境中招募了 6 名临床医生。
该研究评估了社会人口统计学特征、移动医疗产品使用史以及对基于智能手机的 VA 评估工具的优势和潜在缺点的看法。
研究人群中,有 14.4%的人之前使用过移动医疗产品。调整协变量后,年龄较小(p=0.001)、男性(p=0.01)和收入较高(>$45000)与使用移动医疗产品的可能性增加相关(p=0.005)。72%的参与者愿意使用自动基于智能手机的 VA 评估工具,前提是准确性与人类评估者相当。便利性(37.3%)和节省成本(15.5%)被认为是最大的优势。而测试准确性(50.6%)、缺乏与医疗保健提供者的个人联系(18.3%)和数据安全(11.9%)则是最大的顾虑。从临床医生定性数据中出现的主题包括在患者中识别屈光不正的潜在好处,以及自我监测视力的能力。人们对自我测试视力应用程序的潜在滥用以及无法检测病理的问题表示担忧。
我们的研究结果表明,澳大利亚有相当一部分人口不使用移动医疗产品。此外,临床医生和公众对基于智能手机的 VA 评估工具仍存在显著的担忧,包括测试准确性和数据隐私。